These medications work through entirely different mechanisms and are metabolised via separate pathways in the body
Preclinical data on GLP-1 and GLP-1 RAs have displayed an impressive neuroprotective efficacy in stroke, Parkinson's disease (PD), Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases
Clinical data shows glucose control becomes more variable in patients on both drugs
Benefits of the GLP-1 Program Supports sustainable weight loss Helps reduce cravings and late-night snacking Improves blood sugar regulation May reduce risk factors associated with obesity (high blood pressure, diabetes, cholesterol) Personalized medical oversight from experienced providers Weekly or monthly check-ins to keep you on track How the Program Works Initial Consultation We discuss your health history, current habits, and weight loss goals
After about a year without treatment with semaglutide, net weight loss was down to 5.5%
People who use it consistently tend to notice their skin firming up, the appearance of fine lines fading into the background, while hair looks and feels thicker